Intratumoral, not circulating, endothelial progenitor cells share genetic aberrations with glial tumor cells

Journal of Cellular Physiology

Volumn 228, Issue 7, 2013, Pages 1383-1390

  Zheng, Ping Pin ^a   van der Weiden, Marcel ^a   van der Spek, Peter J ^a   Vincent, Arnaud J P E ^a   Kros, Johan M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VASCULOTROPIN;

ADULT; AGED; ANEUSOMY; ARTICLE; CELL POPULATION; CELL TRANSDIFFERENTIATION; CENTROSOME; CHROMOSOME 10; CHROMOSOME 7; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENETIC DAMAGE; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MONOSOMY; NEOVASCULARIZATION (PATHOLOGY); NUMERICAL CHROMOSOME ABERRATION; POLYSOMY; PRIORITY JOURNAL; STEM CELL NICHE; SUBVENTRICULAR ZONE; TUMOR CELL;

ADULT; AGED; ANEUPLOIDY; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 7; ENDOTHELIAL CELLS; FEMALE; GENES, ERBB-1; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PTEN PHOSPHOHYDROLASE;

EID: 84875506599     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24309     Document Type: Article

References (53)

1. Annabi B, Naud E, Lee YT, Eliopoulos N, Galipeau J. 2004. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J Cell Biochem 91: 1146-1158.
2. Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, Frenkel V, Khuu HM, Read EJ, Frank JA. 2006. Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24: 671-678.
3. Dome B, Dobos J, Tovari J, Paku S, Kovacs G, Ostoros G, Timar J. 2008. Circulating bone marrow-derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry A 73: 186-193.
4. Farace F, Gross-Goupil M, Tournay E, Taylor M, Vimond N, Jacques N, Billiot F, Mauguen A, Hill C, Escudier B. 2011. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Br J Cancer 104: 1144-1150.
5. French SW, Hoyer KK, Shen RR, Teitell MA. 2002. Transdifferentiation and nuclear reprogramming in hematopoietic development and neoplasia. Immunol Rev 187: 22-39.
6. Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal V. 2009. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 1796: 33-40.
7. Greenfield JP, Jin DK, Young LM, Christos PJ, Abrey L, Rafii S, Gutin PH. 2009. Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme. Neurosurgery 64: 819-826; discussion 826-817.
8. Hess DA, Allan AL. 2011. Migratory strategies of normal and malignant stem cells. Methods Mol Biol 750: 25-44.
9. Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M. 2004. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
10. Igreja C, Courinha M, Cachaco AS, Pereira T, Cabecadas J, da Silva MG, Dias S. 2007. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 92: 469-477.
11. Jain S, Ward MM, O'Loughlin J, Boeck M, Wiener N, Chuang E, Cigler T, Moore A, Donovan D, Lam C, Cobham MV, Schneider S, Christos P, Baergen RN, Swistel A, Lane ME, Mittal V, Rafii S, Vahdat LT. 2011. Incremental increase in VEGFR1(+) hematopoietic progenitor cells and VEGFR2(+) endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. Breast Cancer Res Treat 132: 235-242.
12. Janssen A, Medema RH. 2011. Entosis: Aneuploidy by invasion. Nat Cell Biol 13: 199-201.
13. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. 2010. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120: 694-705.
14. Kopp HG, Ramos CA, Rafii S. 2006. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 13: 175-181.
15. Korshunov A, Sycheva R, Golanov A. 2004. Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: The utility of fluorescence in situ hybridization. Clin Cancer Res 10: 7820-7826.
16. Korshunov A, Sycheva R, Golanov A. 2005. The prognostic relevance of molecular alterations in glioblastomas for patients age <50 years. Cancer 104: 825-832.
17. Kramar F, Zemanova Z, Michalova K, Babicka L, Ransdorfova S, Hrabal P, Kozler P. 2007. Cytogenetic analyses in 81 patients with brain gliomas: Correlation with clinical outcome and morphological data. J Neurooncol 84: 201-211.
18. Kramer A, Maier B, Bartek J. 2011. Centrosome clustering and chromosomal (in)stability: A matter of life and death. Mol Oncol 5: 324-335.
19. Kuczynski EA, Patten SG, Coomber BL. 2011. VEGFR2 expression and TGF-beta signaling in initial and recurrent high-grade human glioma. Oncology 81: 126-134.
20. Kuo KK, Sato N, Mizumoto K, Maehara N, Yonemasu H, Ker CG, Sheen PC, Tanaka M. 2000. Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts. Hepatology 31: 59-64.
21. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. 2002. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32: 355-357.
22. Li Calzi S, Neu MB, Shaw LC, Kielczewski JL, Moldovan NI, Grant MB. 2010. EPCs and pathological angiogenesis: When good cells go bad. Microvasc Res 79: 207-216.
23. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
24. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846.
25. Moore XL, Lu J, Sun L, Zhu CJ, Tan P, Wong MC. 2004. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 11: 811-818.
26. Naik RP, Jin D, Chuang E, Gold EG, Tousimis EA, Moore AL, Christos PJ, de Dalmas T, Donovan D, Rafii S, Vahdat LT. 2008. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat 107: 133-138.
27. Nielsen JS, McNagny KM. 2008. Novel functions of the CD34 family. J Cell Sci 121: 3683-3692.
28. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, Heikamp E, McDevitt MR, Scheinberg DA, Benezra R, Mittal V. 2007. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 21: 1546-1558.
29. Patenaude A, Parker J, Karsan A. 2010. Involvement of endothelial progenitor cells in tumor vascularization. Microvasc Res 79: 217-223.
30. Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E, Bengzon J, Jacobsen SE, Nuber UA. 2007. CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells. Cancer Res 67: 5727-5736.
31. Plate KH, Breier G, Millauer B, Ullrich A, Risau W. 1993. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827.
32. Rafat N, Beck G, Schulte J, Tuettenberg J, Vajkoczy P. 2010. Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg 112: 43-49.
33. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R. 2010. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-828.
34. Sakariassen PO, Immervoll H, Chekenya M. 2007. Cancer stem cells as mediators of treatment resistance in brain tumors: Status and controversies. Neoplasia 9: 882-892.
35. Santarelli JG, Udani V, Yung YC, Cheshier S, Wagers A, Brekken RA, Weissman I, Tse V. 2006. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery 59: 374-382; discussion 374-382.
36. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, Costa C, Zhang F, Guo X, Rafii S. 2004. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 103: 2055-2061.
37. Sinkovics JG. 2009. Horizontal gene transfers and cell fusions in microbiology, immunology and oncology (Review). Int J Oncol 35: 441-465.
38. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM. 2011. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 108: 4274-4280.
39. Srividya MR, Thota B, Shailaja BC, Arivazhagan A, Thennarasu K, Chandramouli BA, Hegde AS, Santosh V. 2011. Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: A prospective translational study on a uniformly treated cohort of adult patients. Neuropathology 31: 376-383.
40. Streubel B, Chott A, Huber D, Exner M, Jager U, Wagner O, Schwarzinger I. 2004. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med 351: 250-259.
41. Su Y, Zheng L, Wang Q, Li W, Cai Z, Xiong S, Bao J. 2010. Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer. J Exp Clin Cancer Res 29: 27.
42. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S, Tanino M, Nishihara H, Tanaka S. 2008. Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 18: 1037-1046.
43. Torsney E, Xu Q. 2011. Resident vascular progenitor cells. J Mol Cell Cardiol 50: 304-311.
44. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK. 2003. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197: 1755-1765.
45. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. 2010. Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
46. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V. 2010. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833.
47. Wang S, Fang J, Zhang T, Wang B, Chen J, Li X, Zhang S, Zhang W. 2011. Magnetic resonance imaging targeting of intracranial glioma xenografts by Resovist-labeled endothelial progenitor cells. J Neurooncol 105: 67-75.
48. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. 1993. Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118: 489-498.
49. Zhang HR, Chen FL, Xu CP, Ping YF, Wang QL, Liang ZQ, Wang JM, Bian XW. 2009. Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft. J Neurooncol 93: 165-174.
50. Zheng PP, Sieuwerts AM, Luider TM, van der Weiden M, Sillevis-Smitt PA, Kros JM. 2004. Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature. Am J Pathol 164: 2217-2228.
51. Zheng PP, Hop WC, Luider TM, Sillevis Smitt PA, Kros JM. 2007a. Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas. Ann Neurol 62: 40-48.
52. Zheng PP, van der Weiden M, Kros JM. 2007b. Hela l-CaD is implicated in the migration of endothelial cells/endothelial progenitor cells in human neoplasms. Cell Adh Migr 1: 84-91.
53. Zheng PP, Weiden M, Sillevis Smitt PA, Luider TM, Kros JM. 2007c. Hela/-CaD undergoes a DNA replication-associated switch in localization from the cytoplasm to the nuclei of endothelial cells/endothelial progenitor cells in human tumor vasculature. Cancer Biol Ther 6: 886-890.